Top Stories
Hedge fund performance fees, I believe, are a rip-off for clients. Few…
BioVaxys Technology Corp. is developing its patented DPX™ platform to address the challenges of lipid nanoparticles (LNPs) in mRNA vaccine delivery. Learn how DPX improves stability, immune responses, and manufacturing economics as the mRNA vaccine market projects $48 billion growth by 2030.
A look at the day ahead in European and global markets…
Investing.com– Chinese chipmaking stocks, especially those in the foundry sector, rose…
WASHINGTON (Reuters) -Billionaire Elon Musk’s hand gesture while he spoke during…
By Jarrett Renshaw (Reuters) – U.S. President Donald Trump issued a…
Investments
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…
Economy Insights
National News
Investing.com — Here are the biggest analyst moves in the area of artificial intelligence (AI) for this week. InvestingPro subscribers always get first dibs on market-moving AI…
Image source: Getty Images Unlike the Hokey Cokey, buying shares when they trade below their intrinsic value is what investing is all about. But if it was…
‘If I turn up on your doorstep you’re likely getting thousands – sometimes millions’ By Megan Harwood-Baynes, cost of living specialistIf Ryan Gregory turns up on your doorstep,…
Investing.com — UBS has released its market outlook for platinum group metals (PGMs), forecasting that will outperform in 2025, although both are expected to lag behind and…
Image source: Getty Images Latest figures (March 2023) from HMRC reveal that £725.9bn’s been invested in Stocks and Shares ISAs. Although this sounds like a lot, it’s…
(Reuters) -Here are the main elements of a Gaza ceasefire deal that went into effect on Sunday after 15 months of conflict that has killed tens of…